Am J Cardiol

1. ITO T, Mori Y, Kohsaka S, Yamaji K, et al
   Effects of Transradial Access on In-Hospital Outcomes in Percutaneous Coronary Intervention for Coronary Artery Bypass Graft: Insights from the Japanese Nationwide Database.
   Am J Cardiol. 2024 Jun 29:S0002-9149(24)00458.
   

   >> Share

   
   

   
   Ann Thorac Surg

2. BRLECIC PE, Hogan KJ, Treffalls JA, Sylvester CB, et al
   Safety of Early Discharge After Coronary Artery Bypass Grafting: A Nationwide Readmissions Analysis.
   Ann Thorac Surg. 2024 Jun 29:S0003-4975(24)00537.
   

   >> Share

   
   

   
   BMJ

3. 
   Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73).
   BMJ. 2024;385:q1450.
   

   >> Share

   
   

   
   Circ Cardiovasc Qual Outcomes

4. DI PALO KE, Feder S, Baggenstos YT, Cornelio CK, et al
   Palliative Pharmacotherapy for Cardiovascular Disease: A Scientific Statement From the American Heart Association.
   Circ Cardiovasc Qual Outcomes. 2024 Jul 1:e000131.
   

   >> Share

   
   

   
   Circ Genom Precis Med

5. DENG K, Gupta DK, Shu XO, Lipworth L, et al
   Circulating Metabolite Profiles and Risk of Coronary Heart Disease Among Racially and Geographically Diverse Populations.
   Circ Genom Precis Med. 2024 Jul 1:e004437. doi: 10.1161/CIRCGEN.123.004437.
   

   >> Share

   
   

   
   Circulation

6. REITAN C, Andell P, Alfredsson J, Erlinge D, et al
   Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study.
   Circulation. 2024 Jul 5. doi: 10.1161/CIRCULATIONAHA.124.068739.
   

   >> Share

   
   
7. BERRY C, Sidik NP, McEntegart MB
   Response by Berry et al to Letter Regarding Article, "Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial".
   Circulation. 2024;150:e5-e6.
   

   >> Share

   
   
8. NISHI T, Saito Y, Kobayashi Y
   Letter by Nishi et al Regarding Article, "Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial".
   Circulation. 2024;150:e3-e4.
   

   >> Share

   
   

   
   Clin Cardiol

9. HOSSEINPOUR A, Sood A, Kamalpour J, Zandi E, et al
   Glucagon-Like Peptide-1 Receptor Agonists and Major Adverse Cardiovascular Events in Patients With and Without Diabetes: A Meta-Analysis of Randomized-Controlled Trials.
   Clin Cardiol. 2024;47:e24314.
   

   >> Share

   
   
10. HOU J, Sun Y, Wang H, Zhang L, et al
    Papillary Muscle Infarction by Cardiac MRI in Patients With Mitral Regurgitation.
    Clin Cardiol. 2024;47:e24312.
    

    >> Share

    
    
11. ARJOMANDI RAD A, Tserioti E, Magouliotis DE, Vardanyan R, et al
    Assessment of Myocardial Viability in Ischemic Cardiomyopathy With Reduced Left Ventricular Function Undergoing Coronary Artery Bypass Grafting.
    Clin Cardiol. 2024;47:e24307.
    

    >> Share

    
    
12. CHANG CC, Sung WT, Lu YW, Chuang MJ, et al
    Real-World Clinical Performance of a Novolimus-Eluting Stent Versus a Sirolimus-Eluting Stent.
    Clin Cardiol. 2024;47:e24317.
    

    >> Share

    
    
13. RESHADMANESH T, Behnoush AH, Farajollahi M, Khalaji A, et al
    Circulating Levels of Calprotectin as a Biomarker in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Clin Cardiol. 2024;47:e24315.
    

    >> Share

    
    

    
    Eur Heart J

14. SCHELDEMAN L, Sinnaeve P, Albers GW, Lemmens R, et al
    Acute myocardial infarction and ischaemic stroke: differences and similarities in reperfusion therapies-a review.
    Eur Heart J. 2024 Jun 28:ehae371. doi: 10.1093.
    

    >> Share

    
    

    
    Int J Cardiol

15. KUBAT GB
    The importance of platelet-derived mitochondrial transplantation in ischemic heart disease: A clinical study.
    Int J Cardiol. 2024;412:132312.
    

    >> Share

    
    
16. CORDERO A, Oterino A
    Individualization of prasugrel dose for patients with acute myocardial infarction.
    Int J Cardiol. 2024 Jun 29:132313. doi: 10.1016/j.ijcard.2024.132313.
    

    >> Share

    
    
17. SIGLE M, Faller W, Heurich D, Zdanyte M, et al
    Machine learning predicts emergency physician specialties from treatment strategies for patients suspected of myocardial infarction.
    Int J Cardiol. 2024 Jul 2:132332. doi: 10.1016/j.ijcard.2024.132332.
    

    >> Share

    
    
18. BASEM M, Bonnesen K, Schmidt M
    Potential of the Danish Comorbidity Index for Acute Myocardial Infarction to discriminate mortality in patients with infective endocarditis.
    Int J Cardiol. 2024 Jul 2:132328. doi: 10.1016/j.ijcard.2024.132328.
    

    >> Share

    
    

    
    J Am Coll Cardiol

19. CARVALHO MF, Cabral M, Goncalves C, Graca Santos L, et al
    An Intramyocardial Mass Mimicking ST-Segment Elevation Myocardial Infarct at Presentation.
    J Am Coll Cardiol. 2024;84:229-231.
    

    >> Share

    
    
20. SANDNER S, Redfors B, An KR, Harik L, et al
    Coronary Artery Bypass Graft Failure in Women: Incidence and Clinical Implications.
    J Am Coll Cardiol. 2024;84:182-191.
    

    >> Share

    
    
21. ARNOLD N, Blaum C, Gossling A, Brunner FJ, et al
    Impact of Lipoprotein(a) Level on Low-Density Lipoprotein Cholesterol- or Apolipoprotein B-Related Risk of Coronary Heart Disease.
    J Am Coll Cardiol. 2024;84:165-177.
    

    >> Share

    
    
22. A FRY ET
    Private Equity in Cardiovascular Practice: Solution or Symptom.
    J Am Coll Cardiol. 2024 Jun 21:S0735-1097(24)07610.
    

    >> Share

    
    
23. LINCOFF AM, Ray KK, Sasiela WJ, Haddad T, et al
    Comparative Cardiovascular Benefits of Bempedoic Acid and Statin Drugs.
    J Am Coll Cardiol. 2024;84:152-162.
    

    >> Share

    
    

    
    J Cardiovasc Pharmacol

24. KARAKASIS P, Patoulias D, Giannakoulas G, Fragakis N, et al
    Are We Ready for Expanding the Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Acute Myocardial Infarction?
    J Cardiovasc Pharmacol. 2024;84:26-28.
    

    >> Share

    
    
25. ZHANG X, Sun G, Li Z, Gao W, et al
    Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Acute Myocardial Infarction With or Without Type 2 Diabetes: A Systematic Review and Meta-analysis.
    J Cardiovasc Pharmacol. 2024;84:18-25.
    

    >> Share

    
    
26. SIKORSKA M, Chmiel J, Papuga-Szela E, Broniatowska E, et al
    Apixaban Versus Vitamin K Antagonists in Patients With Antiphospholipid Syndrome: A Cohort Study.
    J Cardiovasc Pharmacol. 2024;84:36-44.
    

    >> Share

    
    

    
    J Mol Cell Cardiol

27. LAHIRI SK, Lu J, Aguilar-Sanchez Y, Li H, et al
    Targeting Calpain-2-mediated Junctophilin-2 cleavage delays heart failure progression following myocardial infarction.
    J Mol Cell Cardiol. 2024 Jul 1:S0022-2828(24)00108.
    

    >> Share

    
    

    
    JAMA

28. NICHOLLS SJ, Lam CSP, Nelson AJ
    Cardiovascular Clinical Trials in the Asia-Pacific Region.
    JAMA. 2024 Jul 1. doi: 10.1001/jama.2024.6313.
    

    >> Share

    
    

    
    Mayo Clin Proc

29. VALLABHAJOSYULA S, Abbott JD, Kapur NK
    The Need to Define High-Dose Pharmacological Circulatory Support in Cardiogenic Shock.
    Mayo Clin Proc. 2024;99:1035-1037.
    

    >> Share

    
    
30. ABDELAZIZ A, Hafez A, Abdelaziz M, Atta K, et al
    Empagliflozin and Cardiovascular Outcomes Across Urine Albumin to Creatinine Ratio Categories: A Systematic Review and Meta-analysis.
    Mayo Clin Proc. 2024;99:1188-1191.
    

    >> Share

    
    

    
    N Engl J Med

31. CLELAND JGF, McMurray JJV, Freemantle N
    Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.
    N Engl J Med. 2024;391:94.
    

    >> Share

    
    
32. KOMAMURA K, Kobayashi K, Iwase M
    Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.
    N Engl J Med. 2024;391:94-95.
    

    >> Share

    
    
33. YNDIGEGN T, Hofmann R, Jernberg T
    Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction. Reply.
    N Engl J Med. 2024;391:95.
    

    >> Share

    
    

    
    PLoS One

34. HUI D, Sanford E, Lorenz K, Damrauer SM, et al
    Mendelian randomization analyses clarify the effects of height on cardiovascular diseases.
    PLoS One. 2024;19:e0298786.
    

    >> Share

    
    
35. THOMPSON G, Caughers G, Bradley J, Donnelly P, et al
    The feasibility of delivering cardiac brief intervention to patients following ST-elevation myocardial infarction: Protocol for a pilot randomised controlled trial.
    PLoS One. 2024;19:e0306406.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share